scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S1383-5742(98)00018-0 |
P698 | PubMed publication ID | 9878689 |
P2093 | author name string | Jirtle RL | |
Falls JG | |||
Pulford DJ | |||
Killian JK | |||
P2860 | cites work | The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor | Q24316544 |
IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes | Q24317066 | ||
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity | Q28284646 | ||
Tumour-suppressor activity of H19 RNA | Q59071440 | ||
Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour | Q59088779 | ||
Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours | Q63407701 | ||
Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7 | Q68118181 | ||
The propensity to malignancy of dispermic heterozygous moles | Q69808089 | ||
Choline deficiency and methotrexate treatment induces marked but reversible changes in hepatic folate concentrations, serum homocysteine and DNA methylation rates in rats | Q70790075 | ||
Loss of imprinting in human cancer | Q71809673 | ||
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification | Q72228209 | ||
Human insulin-like growth factor type I and type II receptors are not imprinted | Q72250045 | ||
Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor | Q73155765 | ||
Disruption of imprinting caused by deletion of the H19 gene region in mice | Q28287765 | ||
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance | Q29616511 | ||
Role for DNA methylation in genomic imprinting | Q29618669 | ||
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting | Q30450833 | ||
Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors | Q34236758 | ||
Parental imprinting and human disease | Q34412350 | ||
Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. | Q34429732 | ||
The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus | Q34776140 | ||
Genomic imprinting: a chromatin connection | Q35250186 | ||
Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene | Q35793734 | ||
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) | Q36081417 | ||
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas | Q36431650 | ||
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis | Q36586442 | ||
Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. | Q36772949 | ||
Genomic imprinting and the strange case of the insulin-like growth factor II receptor | Q37165552 | ||
Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues | Q37679466 | ||
Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory | Q38367968 | ||
Parthenogenic Origin of Benign Ovarian Teratomas | Q39916254 | ||
Gametic imprinting in mammals | Q40383353 | ||
The molecular basis of oncogenes and tumor suppressor genes. | Q40454392 | ||
Imprinting the genome: imprinted genes, imprinting genes, and a hypothesis for their interaction | Q40722195 | ||
DNA methylation and genomic imprinting | Q40754526 | ||
Epigenetic regulation of gene expression: the effect of altered chromatin structure from yeast to mammals | Q40934967 | ||
The Wellcome Prize Lecture. Genetic imprinting: the battle of the sexes rages on. | Q40947455 | ||
Creation of genomic methylation patterns | Q40986760 | ||
Genomic imprinting in tumours | Q41025105 | ||
Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors | Q41178952 | ||
Conservation of a maternal-specific methylation signal at the human IGF2R locus | Q41285894 | ||
The role of DNA methylation in cancer genetic and epigenetics | Q41291310 | ||
Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains | Q41381587 | ||
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene | Q41415190 | ||
DNA methylation in genomic imprinting | Q41439642 | ||
Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis | Q41480764 | ||
Genomic imprinting in the brain | Q41587298 | ||
Genetic polymorphisms in human drug metabolic enzymes | Q41661446 | ||
Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. | Q45985336 | ||
Promoter-specific imprinting of the human insulin-like growth factor-II gene | Q46095293 | ||
Height depends on month of birth | Q47294580 | ||
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors | Q47886657 | ||
Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis | Q48049008 | ||
Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors | Q48063609 | ||
Mosaic and polymorphic imprinting of the WT1 gene in humans | Q48084685 | ||
Imprinted genes in liver carcinogenesis. | Q50973629 | ||
Imprinting and the initiation of gene silencing in the germ line. | Q52187741 | ||
A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. | Q52241373 | ||
Relaxation of imprinted genes in human cancer. | Q52545355 | ||
Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. | Q52868711 | ||
Hereditary predisposition to cancer. | Q53433894 | ||
Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
Functional Polymorphism in the Parental Imprinting of the Human IGF2R Gene | Q57500167 | ||
The insulin–like growth factor type–2 receptor gene is imprinted in the mouse but not in humans | Q58061470 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 59-67 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Mutation Research | Q6943732 |
P1476 | title | Polymorphisms, genomic imprinting and cancer susceptibility. | |
P478 | volume | 436 |
Q30321053 | A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility? |
Q39740934 | A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma |
Q42662678 | Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue |
Q35803624 | Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer |
Q42506184 | Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. |
Q33852775 | Imprinted genes as potential genetic and epigenetic toxicologic targets |
Q47421477 | Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors |
Q43663105 | Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations |
Q28364163 | Methylation matters |
Q33622981 | Modeling the aneuploidy control of cancer |
Q34085483 | Monotreme IGF2 expression and ancestral origin of genomic imprinting |
Q73952741 | Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome |
Q33907630 | Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol |
Q58793650 | TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis |
Search more.